HomeInsightsStock Comparison

Dishman Carbogen Amcis Ltd vs Sun Pharma Advanced Research Company Ltd Stock Comparison

Dishman Carbogen Amcis Ltd vs Sun Pharma Advanced Research Company Ltd Stock Comparison

Last Updated on: Apr 30, 2025

Key Highlights

  • The Latest Trading Price of Dishman Carbogen Amcis Ltd is ₹ 201.35 as of 30 Apr 10:15.
  • The P/E Ratio of Dishman Carbogen Amcis Ltd changed from 5.3 on March 2020 to 161 on March 2022 . This represents a CAGR of 212.02% over 3 yearsThe P/E Ratio of Sun Pharma Advanced Research Company Ltd changed from 0 on March 2023 to 0 on March 2022 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Dishman Carbogen Amcis Ltd changed from ₹ 1955 crore on March 2023 to ₹ 2902 crore on March 2022 . This represents a CAGR of 8.23% over 5 yearsThe Market Cap of Sun Pharma Advanced Research Company Ltd changed from ₹ 5823 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 5 years.
  • The revenue of Dishman Carbogen Amcis Ltd for the Dec '24 is ₹ 690.01 crore as compare to the Sep '24 revenue of ₹ 795.69 crore. This represent the decline of -13.28% The revenue of Sun Pharma Advanced Research Company Ltd for the Dec '24 is ₹ 15.1 crore as compare to the Sep '24 revenue of ₹ 12.9 crore. This represent the growth of 17.05%.
  • The ebitda of Dishman Carbogen Amcis Ltd for the Dec '24 is ₹ 147.8 crore as compare to the Sep '24 ebitda of ₹ 150.84 crore. This represent the decline of -2.02% The ebitda of Sun Pharma Advanced Research Company Ltd for the Dec '24 is ₹ -73.5 crore as compare to the Sep '24 ebitda of ₹ -102 crore. This represent the decline of -28.55%.
  • The net profit of Dishman Carbogen Amcis Ltd changed from ₹ 17 crore to ₹ 4.63 crore over 7 quarters. This represents a CAGR of -52.44% The net profit of Sun Pharma Advanced Research Company Ltd changed from ₹ -95.35 crore to ₹ -79.51 crore over 7 quarters. This represents a CAGR of -9.86% .
  • The Dividend Payout of Dishman Carbogen Amcis Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sun Pharma Advanced Research Company Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Dishman Carbogen Amcis Ltd

  • Dishman Carbogen Amcis Limited was formerly incorporated as Carbogen Amcis (India) Limited on July 17, 2007.
  • The Company name later on was changed to Dishman Carbogen Amcis Limited effective from 27 March 2017.
  • The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries.
  • It has manufacturing and research facilities in India, Switzerland, France, The Netherland and China. During the financial year ended 31 March 2017, Dishman Pharmaceuticals and Chemicals Limited (DPCL) and Dishman Care Limited were merged with DPCL's subsidiary Carbogen Amcis (India) Limited, with the key objective of business consolidation and simplification of the Group structure.

About Sun Pharma Advanced Research Company Ltd

  • Sun Pharma Advanced Research Company Ltd. (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems.
  • The Company works on innovation and new product development for global markets.
  • They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). Sun Pharmaceutical Advanced Research Company Ltd was incorporated on March 1, 2006 as an innovative and development company.
  • They commenced operations on March 22, 2006.
  • As per Scheme of Arrangement, all assets and liabilities of the Innovative Research & Development business including Novel Drug Delivery System (NDDS) division of Sun Pharmaceuticals Industries' Research & Development undertaking stands transferred and vested in the Company with effect from Appointed date on February 28, 2007.

Dishman Carbogen Amcis Ltd News Hub

News

Dishman Carbogen Amcis' Shanghai facility clears China regulatory compliance

Dishman Carbogen Amcis announced that its Shanghai facility has successfully obtained its ...

Read more

21 Apr 2025 19:33

News

Dishman Carbogen Amcis receives affirmation in credit ratings

Dishman Carbogen Amcis has received affirmation in credit ratings from India Ratings and R...

Read more

16 Apr 2025 19:56

News

Dishman Carbogen Amcis allots NCDs aggregating Rs 50 cr

Dishman Carbogen Amcis has allotted 5,000 Rated, Listed, Senior, Secured, Redeemable, Taxa...

Read more

26 Mar 2025 12:35

News

Dishman Carbogen Amcis to hold board meeting

Dishman Carbogen Amcis will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

08 Mar 2025 10:27

News

Dishman Carbogen Amcis to announce Quarterly Result

Dishman Carbogen Amcis will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

10 Feb 2025 10:30

News

Dishman Carbogen Amcis announces of change in CEO of Carbogen Amcis entities

Dishman Carbogen Amcis announced that Pascal Villemagne, CEO of Carbogen Amcis entities (c...

Read more

03 Feb 2025 15:37

Sun Pharma Advanced Research Company Ltd News Hub

News

Sun Pharma Advanced Research Company submits IND application to USFDA

Sun Pharma Advanced Research Company announced submission of an Investigational New Drug (...

Read more

31 Mar 2025 10:19

News

SPARC submits application for its ADC to US FDA to conduct global phase-1 study

The IND application supports the next phase of development of SBO-154 which has completed ...

Read more

31 Mar 2025 13:58

News

Volumes jump at Sun Pharma Advanced Research Company Ltd counter

Kalpataru Projects International Ltd, Inox Wind Ltd, Data Patterns (India) Ltd, Triveni Tu...

Read more

07 Mar 2025 14:30

News

Sun Pharma Advanced Research Company to hold board meeting

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the ...

Read more

01 Feb 2025 10:56

News

Sun Pharma Advanced Research Company to acquire 55% stake in Tiller Therapeutics

Sun Pharma Advanced Research Company announced the signing of a binding Letter of Intent (...

Read more

17 Dec 2024 09:34

News

Sun Pharma inks pact with UCSF and Tiller Therapeutics

The LoI outlines the key terms of license and rights for development and commercialization...

Read more

17 Dec 2024 10:24

SWOT Analysis Of Dishman Carbogen Amcis Ltd

Strength

1

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Sun Pharma Advanced Research Company Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Dishman Carbogen Amcis Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharma Advanced Research Company Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Dishman Carbogen Amcis Ltd and Sun Pharma Advanced Research Company Ltd

Which company has a larger market capitalization, Dishman Carbogen Amcis Ltd or Sun Pharma Advanced Research Company Ltd?

Market cap of Dishman Carbogen Amcis Ltd is 3,184 Cr while Market cap of Sun Pharma Advanced Research Company Ltd is 4,824 Cr

What are the key factors driving the stock performance of Dishman Carbogen Amcis Ltd and Sun Pharma Advanced Research Company Ltd?

The stock performance of Dishman Carbogen Amcis Ltd and Sun Pharma Advanced Research Company Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dishman Carbogen Amcis Ltd and Sun Pharma Advanced Research Company Ltd?

As of April 30, 2025, the Dishman Carbogen Amcis Ltd stock price is INR ₹203.1. On the other hand, Sun Pharma Advanced Research Company Ltd stock price is INR ₹148.65.

How do dividend payouts of Dishman Carbogen Amcis Ltd and Sun Pharma Advanced Research Company Ltd compare?

To compare the dividend payouts of Dishman Carbogen Amcis Ltd and Sun Pharma Advanced Research Company Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions